First Trust Nasdaq Pharma... (FTXH)
NASDAQ: FTXH
· Real-Time Price · USD
27.50
-0.07 (-0.24%)
At close: Aug 18, 2025, 3:55 PM
27.47
-0.09%
After-hours: Aug 18, 2025, 04:10 PM EDT
-0.24% (1D)
| Bid | 22.25 |
| Market Cap | 14.17M |
| AUM | 14.99M |
| NAV | 27.26 |
| EPS (ttm) | 1.51 |
| PE Ratio (ttm) | 18.18 |
| Shares Out | 515.46K |
| Inception Date | Sep 20, 2016 |
| Ask | 29 |
| Volume | 1.27K |
| Open | 27.64 |
| Previous Close | 27.57 |
| Day's Range | 27.50 - 27.64 |
| 52-Week Range | 23.29 - 29.72 |
| Holdings | 51 |
| Expense Ratio | 0.60% |
About FTXH
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
Asset Class Pharmaceuticals
Ticker Symbol FTXH
Inception Date Sep 20, 2016
Provider First Trust
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 54.18% of assets
| Name | Symbol | Weight |
|---|---|---|
| Johnson & Johnson | JNJ | 7.93% |
| Pfizer Inc. | PFE | 7.41% |
| Abbvie Inc. | ABBV | 6.98% |
| Merck & Co., Inc. | MRK | 6.89% |
| Bristol-myers Squibb... | BMY | 6.28% |
| Viatris Inc. | VTRS | 3.90% |
| Amgen Inc. | AMGN | 3.87% |
| Gilead Sciences, Inc... | GILD | 3.75% |
| United Therapeutics ... | UTHR | 3.63% |
| Biogen Inc. | BIIB | 3.54% |
Dividends Dividend Yield 1.72%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jun 26, 2025 | $0.0892 | Jun 30, 2025 |
| Mar 27, 2025 | $0.0992 | Mar 31, 2025 |
| Dec 13, 2024 | $0.1304 | Dec 31, 2024 |
| Sep 26, 2024 | $0.1218 | Sep 30, 2024 |
| Jun 27, 2024 | $0.1284 | Jun 28, 2024 |
